Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial
- PMID: 27904554
- PMCID: PMC5121998
- DOI: 10.4103/1735-1995.177355
Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial
Abstract
Background: Type II diabetes mellitus (T2DM) is the prevalent type of diabetes in the world. Prediabetic patients are the most probable group to get diabetes. Several studies have mentioned the role of inflammation in the incidence of diabetes. The origin of inflammation can be infection such as Helicobacter pylori (HP) infection. This study was designed to explore the effect of HP eradication on insulin resistance.
Materials and methods: This single-blind randomized controlled clinical trial was conducted in 2014-2015. The sample size consisted of 49 individuals who were in prediabetes stage with HP infection. Patients with positive stool antigen were allocated randomly into two groups. The treatment group took medication to eradicate HP infection by the routine method of four-drug eradication. However, placebo capsules and tablets were given to the patients in the placebo group. Then fasting plasma glucose (FPG), fasting plasma insulin (FPI), and quantitative C-reactive protein (CRP) levels were measured and homeostatic model assessment of insulin resistance (HOMA-IR), homeostatic model assessment of beta-cell function (HOMA-B), Matsuda index, insulinogenic index, and disposition index were calculated.
Results: Results of this study showed that FPI and HOMA-IR increased significantly (P value of FPI = 0.023 and P value of HOMA-IR = 0.019) after HP eradication in the treatment group. On the other hand, comparison of differences at the baseline and after 6 weeks in FPG (P value = 0.045), FPI (P value = 0.013), and HOMA-B (P value = 0.038) revealed significant differences between the placebo group and treatment group.
Conclusion: Results showed that HP eradication by a 2-week antibiotic medication did not decrease insulin resistance and even increased FPI and insulin resistance indices. So HP eradication among prediabetic patients is not recommended for the decrease of insulin resistance and postponement of the development of diabetes mellitus.
Keywords: Helicobacter pylori (HP) infection; insulin resistance; prediabetic.
Figures
Similar articles
-
Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation.South Med J. 2010 Mar;103(3):190-6. doi: 10.1097/SMJ.0b013e3181cf373f. South Med J. 2010. PMID: 20134372
-
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients.Nutr Metab Cardiovasc Dis. 2016 Oct;26(10):893-8. doi: 10.1016/j.numecd.2016.06.012. Epub 2016 Jul 1. Nutr Metab Cardiovasc Dis. 2016. PMID: 27480449 Clinical Trial.
-
The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):242-5. doi: 10.5507/bp.2014.036. Epub 2014 Jun 19. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015. PMID: 24993741 Clinical Trial.
-
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.Metabolism. 2010 Jun;59(6):887-95. doi: 10.1016/j.metabol.2009.10.007. Epub 2009 Dec 16. Metabolism. 2010. PMID: 20015525 Clinical Trial.
-
A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.Metabolism. 2013 Dec;62(12):1858-66. doi: 10.1016/j.metabol.2013.08.008. Epub 2013 Sep 16. Metabolism. 2013. PMID: 24050270 Review.
Cited by
-
Anti-diabetics and antimicrobials: Harmony of mutual interplay.World J Diabetes. 2021 Nov 15;12(11):1832-1855. doi: 10.4239/wjd.v12.i11.1832. World J Diabetes. 2021. PMID: 34888011 Free PMC article. Review.
-
H. pylori infection and extra-gastroduodenal diseases.J Biomed Sci. 2018 Aug 29;25(1):65. doi: 10.1186/s12929-018-0469-6. J Biomed Sci. 2018. PMID: 30157866 Free PMC article. Review.
-
The effect of Helicobacter pylori eradication on C-reactive protein: results from a meta-analysis.Arch Med Sci. 2021 Mar 21;18(4):958-964. doi: 10.5114/aoms/130288. eCollection 2022. Arch Med Sci. 2021. PMID: 35832706 Free PMC article. Review.
-
Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients.J Res Med Sci. 2018 Dec 28;23:110. doi: 10.4103/jrms.JRMS_1078_17. eCollection 2018. J Res Med Sci. 2018. PMID: 30693045 Free PMC article.
References
-
- Azizi F. The assessment of relation between lipid distribution and weight change with diabetes incidence in a group of Tehran, district 13 population. Pejouhesh. 2008;32:105–13.
-
- Association AD. 2. Classification and diagnosis of diabetes. Diabetes Care. 2015;38:S8–16. - PubMed
-
- Popp Switzer M, Elhanafi S, San Juan ZT. Change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance. Curr Cardiol Rep. 2015;17:1–5. - PubMed
-
- Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: The pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med. 2009;9:299–314. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous